# To Compare the Response Rate of Noradrenaline vs. Terlipressin in Hepatorenal Syndrome in Patients With Acute on Chronic Liver Failure

> **NCT02573727** · NA · COMPLETED · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 120 (actual)

## Conditions studied

- Acute on Chronic Liver Failure

## Interventions

- **DRUG:** Nor adrenaline + albumin
- **DRUG:** Terlipressin + albumin

## Key facts

- **NCT ID:** NCT02573727
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2017-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02573727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02573727, "To Compare the Response Rate of Noradrenaline vs. Terlipressin in Hepatorenal Syndrome in Patients With Acute on Chronic Liver Failure". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT02573727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*